Novel Imaging Tools in Newly-diagnosed Patients With Cardiac AL Amyloidosis
Status:
Recruiting
Trial end date:
2023-02-28
Target enrollment:
Participant gender:
Summary
This will be a systematic, combined, prospective assessment of the novel echographic, CMR,
and PET imaging tools in newly-diagnosed patients with cardiac AL amyloidosis at baseline and
after treatment.